The Interplay: Key Decisions at the Intersection of Antitrust & Life Sciences - March 2024 | WilmerHale
Calls for Removal of Device Patents Listed in the Orange Book Continue. FTC and Congressional action scrutinizing allegedly “improper” Orange Book listings continued apace in the first...
Source: jdsupra.com